Buyers are standardizing purchasing processes across sites, not just vendors and SKUs, and testing AI only in low-risk uses like inventory.
Device and supply sellers should lead with total cost, standardization and continuity — not unit-price discounts.
Sellers should reposition around the buyer’s actual scorecard: total cost across the contract, continuity of supply and the ability to standardize across sites. That means proof assets procurement can carry into a value-analysis committee — reliability track record, disruption response, inventory visibility — rather than a discount schedule. Marketing aimed only at the clinical user misses where decisions are consolidating: system-level supply chain leaders standardizing process, not just product. If your story cannot answer how you reduce rogue spend and variation across facilities, a cheaper competitor with a standardization story will beat a better product with a price story.
